Furie RA, et al. - In this trial, authors evaluated the long-term safety and effectiveness of belimumab in individuals having SLE who completed BLISS-76. Findings disclosed that the incidence of treatment-related and serious AEs remained stable or declined. Hence, the previously observed safety and efficacy profiles of belimumab in patients with SLE were confirmed by these long-term exposure results.